EXHIBIT 11
US DIAGNOSTIC INC. AND SUBSIDIARIES
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
YEAR ENDED YEAR ENDED
1996 1995
---------- ---------
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
PRIMARY EARNINGS PER SHARE:
Primary Weighted Average Shares of Common Stock
and Common Stock Equivalents Outstanding 13,576 4,996
======== =======
Net Income (Loss) $ (6,331) $ 3,331
======== =======
Earnings (Loss) Per Share - Primary $ (.47) $ .67
======== =======
FULLY DILUTED EARNINGS PER SHARE: (1)
Weighted Average Shares Outstanding 13,576 4,996
Dilutive Effect of Assumed Warrant Conversions 10,886 7,182
-------- -------
Fully Diluted Weighted Average Shares of Common Stock
and Common Stock Equivalents Outstanding 24,462 11,761
======== =======
Net Income (Loss) $ (6,331) $ 3,331
Adjustments to Net Income for Interest Savings 2,837 3,682
-------- -------
Adjusted Net Income (Loss) $ (3,494) $ 7,013
======== =======
Earnings (Loss) Per Share - Fully Diluted $ (.14) $ .60
======== =======
----------
(1) This calculation is submitted for 1996 in accordance with Regulation S-K
Item 601(b)(11) although it is contrary to paragraph 40 of APB Opinion No.
15 because it produces an anti-dilutive result.